The article discusses the immunology of susceptibility and resistance to Leishmania major in mice, focusing on the role of T-helper (Th) 1 and Th2 cells. It highlights that while Th2 responses were initially thought to drive susceptibility, recent studies show that Th1 responses are crucial for resistance. The Th1/Th2 balance is regulated by cytokines such as IL-12 and IL-4, with IL-12 promoting Th1 responses and IL-4 driving Th2 responses. However, the model has been refined, revealing complexities in cytokine regulation and immune mechanisms. In BALB/c mice, a Th2 response is associated with susceptibility, while a Th1 response promotes resistance. However, the Th2 response can persist and influence the outcome, even in resistant mice. The role of IL-12 is critical in redirecting the Th2 response to Th1, and its deficiency leads to susceptibility. The Th2 response is also influenced by factors such as the presence of certain T-cell receptors, the environment, and the type of parasite infection. The article also discusses the role of other cytokines, such as IL-10 and TGF-β, in modulating immune responses. IL-10 can suppress Th1 responses and macrophage activation, while TGF-β can inhibit Th1 cell development. The importance of CD4+ T cells in both Th1 and Th2 responses is emphasized, as well as the role of CD8+ T cells in controlling infection. The study also explores the persistence of Leishmania major in healed mice, showing that parasites can remain in fibroblasts and dendritic cells, leading to latent infections. The role of IL-10 in chronicity is highlighted, as its absence can lead to sterile immunity. The article concludes with implications for vaccine design, emphasizing the need for vaccines that can elicit both Th1 and Th2 responses, sustain IL-12 production, and provide long-lasting immunity.The article discusses the immunology of susceptibility and resistance to Leishmania major in mice, focusing on the role of T-helper (Th) 1 and Th2 cells. It highlights that while Th2 responses were initially thought to drive susceptibility, recent studies show that Th1 responses are crucial for resistance. The Th1/Th2 balance is regulated by cytokines such as IL-12 and IL-4, with IL-12 promoting Th1 responses and IL-4 driving Th2 responses. However, the model has been refined, revealing complexities in cytokine regulation and immune mechanisms. In BALB/c mice, a Th2 response is associated with susceptibility, while a Th1 response promotes resistance. However, the Th2 response can persist and influence the outcome, even in resistant mice. The role of IL-12 is critical in redirecting the Th2 response to Th1, and its deficiency leads to susceptibility. The Th2 response is also influenced by factors such as the presence of certain T-cell receptors, the environment, and the type of parasite infection. The article also discusses the role of other cytokines, such as IL-10 and TGF-β, in modulating immune responses. IL-10 can suppress Th1 responses and macrophage activation, while TGF-β can inhibit Th1 cell development. The importance of CD4+ T cells in both Th1 and Th2 responses is emphasized, as well as the role of CD8+ T cells in controlling infection. The study also explores the persistence of Leishmania major in healed mice, showing that parasites can remain in fibroblasts and dendritic cells, leading to latent infections. The role of IL-10 in chronicity is highlighted, as its absence can lead to sterile immunity. The article concludes with implications for vaccine design, emphasizing the need for vaccines that can elicit both Th1 and Th2 responses, sustain IL-12 production, and provide long-lasting immunity.